A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Seattle Children's Hospital
Universitätsklinikum Hamburg-Eppendorf
Milton S. Hershey Medical Center
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Hackensack Meridian Health
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
Massachusetts General Hospital
Thomas Jefferson University
The University of Texas Health Science Center, Houston